From the FAQ, which can be found here,
https://mebiomed.org.uk/classes/
Note: it lists Fukuda, which was part of the early thinking on the project but which will not now be used, this will be revised in a future update to the FAQ.
Yes, we are aware.
Through continuing our outreach and engagement to and with the patient community.
All members of our PPI (Patient and Public Involvement) steering group,
https://mebiomed.org.uk/ppi-group/, will be involved in spreading the word. These are:
- Sonya Chowdhury, founding charity member of the UK CFS/ME Research Collaborative (CMRC) and CEO, Action for M.E. Sonya chairs this group and is also a Co-Investigator (PPI) on the Management Group
- Andy Devereux-Cooke, representative from the CureME Biobank Steering Group and co-founder of Science for ME forum. Andy is also a Co-Investigator (PPI) on the Management Group
- Countess of Mar, on behalf of Forward M.E. and the people with ME and carers the member organisations represent
- Jim Wilson, representative of the CMRC Patient Advisory Group
- Charles Shepherd, founding charity member of the UK CFS/ME Research Collaborative (CMRC) and Honorary Medical Advisor, ME Association
Forward M.E. membership,
http://www.forward-me.org.uk/LinkedOrganisations.htm, currently consists of:
- Countess of Mar (Chairman)
- Carol Monaghan (MP) Vice Chairman
- Dr Nigel Speight
- Dr William Weir
- Dr Nina Muirhead
- ME Association
- ME Research UK
- Action for ME
- The Young ME Sufferers Trust
- reMemberCFS
- Blue Ribbon for awareness of ME
- Neurological Alliance
- ME Trust
- 25% ME Group
- #MEAction
so we have engaged with almost all the UK ME charities/groups already. Hopefully all of them will spread the word, otherwise why agree to be involved, and as we need to reach as much of the UK patient population as possible AfME will have to be involved as much as any of the other charities/groups. If there are patients who are willing to dismiss the study on the basis that AfME are just one of the patient groups promoting it then I, personally, think it's likely to be a smaller number than those who AfME reach and are willing to engage with it - in other words it's likely to be an unavoidable trade-off which we will have to accept.
We also plan to have direct engagement - members of the PPI team, which if funded will include somebody employed as a PPI coordinator, will be available to visit those patient groups who meet up off-line to talk to them about the study - and it is likely we will do some kind of video updates/Q&As.
So we will be working hard to engage with the community, and we will require the support and help of those in the community who do believe and trust in us to spread the word to enhance the chances of recruiting the number of patients that we will need.
In return I will ask, not just yourself but everyone else reading this, "how else might we convince patients that we are actually trying to help them and that they can trust us?".